Disclosures for "Neuropathy as an adverse effect of proteasomal inhibitors in multiple myeloma treatment: a network meta-analysis")
-
Dr. Garg has nothing to disclose.
-
Avash Das has nothing to disclose.
-
Mr. GUPTA has nothing to disclose.
-
Prof. KUMAR has nothing to disclose.
-
Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. The institution of Dr. Roy has received research support from Martin Shubik Fund for IBM at Yale University.